TNF and Duchenne muscular dystrophy: Meanwhile, the TNF-α blockers infliximab and etanercept and the IL-1 receptor antagonist anakinra, which have already been used for treatment of patients with rheumatoid arthritis and/or other inflammatory diseases [58, 59], could potentially be utilized in mdx mice [30, 57] and DMD patients.